chr2-232407885-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_031313.3(ALPG):c.516T>C(p.His172His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00409 in 1,613,438 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 29 hom. )
Consequence
ALPG
NM_031313.3 synonymous
NM_031313.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.83
Publications
2 publications found
Genes affected
ALPG (HGNC:441): (alkaline phosphatase, germ cell) There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The product of this gene is a membrane bound glycosylated enzyme, localized to testis, thymus and certain germ cell tumors, that is closely related to both the placental and intestinal forms of alkaline phosphatase. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-232407885-T-C is Benign according to our data. Variant chr2-232407885-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 781828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.83 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00551 AC: 838AN: 152138Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
838
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00379 AC: 950AN: 250964 AF XY: 0.00372 show subpopulations
GnomAD2 exomes
AF:
AC:
950
AN:
250964
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00394 AC: 5751AN: 1461182Hom.: 29 Cov.: 47 AF XY: 0.00394 AC XY: 2862AN XY: 726900 show subpopulations
GnomAD4 exome
AF:
AC:
5751
AN:
1461182
Hom.:
Cov.:
47
AF XY:
AC XY:
2862
AN XY:
726900
show subpopulations
African (AFR)
AF:
AC:
304
AN:
33478
American (AMR)
AF:
AC:
59
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
353
AN:
26136
East Asian (EAS)
AF:
AC:
3
AN:
39700
South Asian (SAS)
AF:
AC:
228
AN:
86186
European-Finnish (FIN)
AF:
AC:
66
AN:
52814
Middle Eastern (MID)
AF:
AC:
36
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
4421
AN:
1111996
Other (OTH)
AF:
AC:
281
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
504
1009
1513
2018
2522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00554 AC: 844AN: 152256Hom.: 7 Cov.: 32 AF XY: 0.00523 AC XY: 389AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
844
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
389
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
374
AN:
41564
American (AMR)
AF:
AC:
34
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
55
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5174
South Asian (SAS)
AF:
AC:
13
AN:
4802
European-Finnish (FIN)
AF:
AC:
8
AN:
10620
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
343
AN:
68008
Other (OTH)
AF:
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
44
88
133
177
221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 08, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ALPG: BP4, BP7, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.